- Male Reproductive Organ Morphological Measurement [CMO:0000150] — Measurement of the form or structure of any organ which is part of the complex of male gonads, associated ducts, and external genitalia concerned with sexual reproduction.
- Male Reproductive Organ Volume [CMO:0001327] — Measurement of the size of the three dimensional space occupied by any male reproductive organ.
- Male Reproductive Organ Weight [CMO:0001326] — The heaviness, that is, the degree to which a physical mass is drawn toward the earth by gravity, of any of the male reproductive organs (any organ which is part of the complex of male gonads, associated ducts, and external genitalia concerned with sexual reproduction).
- Malignant Colorectal Tumor Number [CMO:0001796] — A value or quantity determined by count of malignant colorectal tumors, abnormal growths of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function, which display the properties of anaplasia, invasiveness and metastasis, and which occur in the large intestine, the distal portion of the alimentary canal, especially in the colon and/or rectum, the segment of the large intestine between the cecum and the anal canal.
- Malignant Colorectal Tumor Surface Area Measurement [CMO:0001798] — A measurement of the two-dimensional extent of a planar region comprising the superficial or external aspect of one or more malignant colorectal tumors, abnormal growths of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function, which display the properties of anaplasia, invasiveness and metastasis, and which occur in the large intestine, the distal portion of the alimentary canal, especially in the colon and/or rectum, the segment of the large intestine between the cecum and the anal canal.
- Malignant Liver Tumor Incidence/prevalence Measurement [CMO:0001710] — Any measurement in which the number of individuals in a study population that display malignant liver tumors at a point in time or develop malignant liver tumors within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A liver tumor is a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive occurring in and composed of cells specific to the liver, the large, dark-red organ located in the cranial portion of the abdomen of vertebrates, just behind or below the diaphragm, the functions of which include storage and filtration of blood; secretion of bile; detoxification of noxious substances; conversion of sugars into glycogen; synthesis and breakdown of fats and temporary storage of fatty acids; and synthesis of serum proteins. Such a tumor is malignant when it displays the properties of anaplasia, invasiveness and metastasis.
- Malignant Liver Tumor Number [CMO:0001708] — A value or quantity determined by count of abnormal, malignant growths of tissue in the liver or in a specified sample of liver tissue, i.e. growths that result from uncontrolled, progressive multiplication of cells, that serve no physiological function, and that display the properties of anaplasia, invasiveness and metastasis. The liver is the large, dark-red organ located in the cranial portion of the abdomen of vertebrates, just behind or below the diaphragm, the functions of which include storage and filtration of blood; secretion of bile; detoxification of noxious substances; conversion of sugars into glycogen; synthesis and breakdown of fats and temporary storage of fatty acids; and synthesis of serum proteins.
- Malignant, Neoplastic Tissue Ribonucleic Acid Level [CMO:0004001] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in a specified malignant, neoplastic tissue.
- Mammary Gland Cancer Ribonucleic Acid Level [CMO:0004006] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in a malignant tumor of the mammary gland(s), a specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only developed in females, and regresses in males.
- Mammary Gland Measurement [CMO:0000786] — Measurement involving the mammary gland, the milk-producing gland in female mammals, consisting of lobes containing clusters of alveoli with a system of ducts to convey the milk to an external nipple or teat.
- Mammary Gland Morphological Measurement [CMO:0001083] — Measurement of the physical form or structure of the mammary gland, the specialized exocrine gland of the skin of female mammals, which secretes milk for nourishment of the young.
- Mammary Gland Ribonucleic Acid Level [CMO:0003977] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in the mammary gland, the specialized exocrine gland of the skin of female mammals, which secretes milk for nourishment of the young.
- Mammary Gland Ribonucleic Acid Level [CMO:0004005] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in the mammary gland(s), a specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only developed in females, and regresses in males.
- Mammary Gland Terminal End Bud Count [CMO:0001084] — Measurement of the number of mammary gland terminal end buds in a specified sample. Terminal end buds are the highly proliferative structures found at the tips of mammary ducts as they elongate into the mammary fat pad during mammary gland development.
- Mammary Gland Tumorous Lesion Measurement [CMO:0000866] — Measurement of a lesion of the mammary gland which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells.
- Mammary Organ Ribonucleic Acid Composition Measurement [CMO:0003275] —
- Mammary Tumor Diameter [CMO:0000346] — The length of a transverse line moving from side to side through the center of a tumor located in the mammary gland.
- Mammary Tumor Growth Rate [CMO:0000344] — The change is size between two points in time for a tumor found within the mammary gland.
- Mammary Tumor Incidence/prevalence Measurement [CMO:0000946] — A measurement in which the number of individuals in a study population displaying one or more tumors of the mammary gland at a point in time or developing such growths within a determined period of time, are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A tumor is an abnormal growth of tissue resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
- Mammary Tumor Measurement [CMO:0000347] — Measurement of an abnormal growth of tissue in the mammary gland resulting from uncontrolled, progressive multiplication of cells and serving no physiological function.
- Mammary Tumor Number [CMO:0000343] — The number of tumors found within the mammary gland.
- Mammary Tumor Weight [CMO:0000348] — The weight of a tumor found within a mammary gland.
- Maternal Age at Birth of First Offspring [CMO:0002510] — The age, that is, the duration of the life of the mother at the point in time when her initial offspring is born; the earliest or youngest age at which a specific individual has given birth.
- Maternal Age at Birth of Last Offspring [CMO:0000391] — The age, that is, the duration of the life of the mother at the point in time when her final offspring is born; the latest or oldest age at which a specific individual has given birth.
- Maternal Age at First Egg Production [CMO:0000390] — The age, that is, the duration of the life of a female bird at the point in time when her initial egg is laid; the earliest or youngest age at which a specific individual has produced an egg.
- Maximal Carbon Dioxide Production (VCO2) [CMO:0000134] — The rate of elimination of carbon dioxide from the lungs.
- Maximal Oxygen Consumption [CMO:0000135] — VO2 max (maximal oxygen consumption), refers to the maximum amount of oxygen that an individual can utilize during intense or maximal exercise. The more oxygen a person can use during high level exercise, the more energy a person can produce. This test is the gold standard for determining cardiorespiratory fitness because the muscles need oxygen for prolonged aerobic exercise, and the heart must pump adequate amounts of blood through the circulation to meet the demands of aerobic exercise.
- Maximal Volume Ventilation [CMO:0000255] — Maximum volume of air that an organism can breathe in and out during a specified period of time, often 1 minute.
- Maximim Inner Diameter of Middle Cerebral Artery Perfused in Bicarbonate-buffered, Calcium-free Saline [CMO:0003997] — This is an ex vivo measurement of the length of a line which crosses a transverse view of a calcium-free physiological salt solution (PSS)-perfused (80 mmHg equilibrium pressure) middle cerebral artery, passing through its center and ending on either side at the inner surface of the blood vessel wall. The middle cerebral arteries are the largest of the cerebral arteries and supply blood to the lateral cerebral cortex, anterior temporal lobes and insular cortices of the brain.
- Maximum Body Weight Loss to Initial Body Weight Ratio [CMO:0001400] — A calculated measurement in which the largest weight loss recorded between two time points or two conditions is divided by the body weight under basal conditions and the result is presented as a ratio, fraction, quotient or percentage.
- Maximum Change in Heart Rate to Change in Mean Arterial Blood Pressure Ratio [CMO:0002037] — Maximum, largest or steepest slope of the line defined by the change in heart rate (the number of contractions of the cardiac ventricles per unit of time) relative to the change in mean arterial blood pressure (the average blood pressure within an artery over a specified period of time) over time and/or in response to a change in conditions.
- Maximum Contractile Force Per Wet Weight of Aorta [CMO:0000728] —
- Maximum Contractile Force Per Wet Weight of Vessel [CMO:0000718] —
- Maximum Distance Run on Treadmill [CMO:0001406] — Measurement of the greatest reached or recorded linear equivalent of the extent of forward progress attained while running on a treadmill, a piece of equipment consisting of a continuously moving belt which allows the action of walking or running without the entire body moving forward.
- Maximum Inspiratory Flow (PIF) [CMO:0000252] —
- Maximum Mid-expiratory Flow (MMEF) [CMO:0000253] — Maximal rate of air flow through the pulmonary tree during forced expiration.
- Maximum Oxygen Consumption to Body Weight Ratio [CMO:0003498] — The maximum amount of oxygen that an individual can utilize during intense or maximal exercise usually measured as volume of oxygen per unit of time, relative to the individual's body weight.
- Maximum Rate of Negative Change in Left Ventricular Blood Pressure [CMO:0001746] — A calculated hemodynamic measurement related to the ability of the heart left ventricle to relax. The point at which the negative pressure fall velocity reaches its peak is taken to be the onset of isovolumic relaxation of the left ventricle.
- Maximum Rate of Positive Change in Left Ventricular Blood Pressure [CMO:0001745] — A calculated measurement that is used as an index to characterize the contractile ability of the heart. It is believed that maximum dP/dt is a reasonable index of the initial velocity of myocardial contraction.
- Maximum Rate of Positive Change in Left Ventricular Blood Pressure to Left Ventricular End-diastolic Volume Ratio [CMO:0002889] —
- Maximum Rate of Positive Change in Left Ventricular Blood Pressure to Left Ventricular Systolic Blood Pressure Ratio [CMO:0003287] — This is a calculated measurement in which the maximum rate of positive change in left ventricular blood pressure in a subject is divided by the left ventricular systolic blood pressure in that subject and presented as a ratio, fraction, quotient or percentage, thus normalizing it to the left ventricular systolic blood pressure.
- Maximum Slope of Body Weight Growth Curve [CMO:0003452] — The maximum slope of a body weight curve is the slope (m in y=mx+c) of the steepest tangent line along the curve, found by differentiating the equation of the curve.
- Maximum Time Spent Running to Exhaustion on Treadmill [CMO:0002306] — A measurement of the amount of time a subject spends running on a treadmill, a piece of equipment consisting of a continuously moving belt which allows the action of walking or running without the entire body moving forward, before exhaustion, that is, privation of energy with consequent inability to respond to stimuli.
- Maximum Trachea Cartilage Thickness [CMO:0003153] — Maximal cartilage thickness was is determined by measuring the perpendicular distance between outer boundaries of cartilage rings.
- Maximum Tumor Size Decrease to Pretreatment Tumor Size Ratio [CMO:0003588] — A calculated value (size of the tumor at the start of therapy minus minimal obtained tumor size, divided by tumor size at the start of therapy x 100) in which the maximum size reduction of a lymphoma is divided by the pretreatment size of the lymphoma and presented as a ratio, fraction or quotient, thus normalizing it to the pretreatment size of the lymphoma.
- Maximum Weekly Bisphenol A in Fructose Drink Intake Rate [CMO:0002176] — The highest per week intake rate of a fructose solution containing bisphenol A consumed as a drink.
- Mean Aortic Pressure [CMO:0003285] — The average pressure (geometric mean) during the aortic pulse cycle.
- Mean Arterial Blood Pressure [CMO:0000009] — The average blood pressure within an artery over a specified period of time. It is often calculated using the formula of one third systolic pressure plus two thirds diastolic pressure, or alternatively, using the formula diastolic pressure plus 1/3 of the difference between systolic pressure and diastolic pressure (i.e. 1/3 pulse pressure).
- Mean Arterial Blood Pressure Variability [CMO:0002811] —
- Mean Arterial Pressure at the Midpoint of A Range of Heart Rates [CMO:0003897] — This calculated value is the value of the mean arterial blood pressure at the midpoint of the curve defined by the change of heart rate relative to the change in mean arterial blood pressure over time and/or in response to a change in conditions.
- Mean Arterial Pressure at the Midpoint of A Range of Renal Sympathetic Nerve Activity [CMO:0003894] — This calculated value is the value of the mean arterial blood pressure at the midpoint of the curve defined by the change of renal sympathetic nerve activity relative to the change in mean arterial blood pressure over time and/or in response to a change in conditions.
- Mean Corpuscular Hemoglobin [CMO:0000290] — The average amount of hemoglobin per red blood cell caculated by dividing the total mass of hemoglobin by the number of red blood cells in a volume of blood.
- Mean Corpuscular Hemoglobin Concentration [CMO:0000291] — This is a measure of the concentration of hemoglobin in a given volume of packed red blood cells.
- Mean Corpuscular Volume [CMO:0000038] — A measure of the average volume or size of a single red blood cell. It is derived by dividing the total volume of packed red blood cells by the total red blood cell count.
- Mean Duration of A Single Spike-and-wave Discharge Train [CMO:0002053] — Measurement of the average duration of a single set of spike and wave discharges, regular, symmetrical, generalized abnormal electrical discharges in the brain, in a series of episodes separated by normal brain activity, i.e. the average length of time which a spike and wave discharge episode lasts.
- Mean Duration of A Single Type I Spike-and-wave Discharge Train [CMO:0002064] — Measurement of the average duration of a single set of type I spike and wave discharges, regular, symmetrical, generalized abnormal electrical discharges in the brain, in a series of episodes separated by normal brain activity, i.e. the average length of time which a type I spike and wave discharge episode lasts. Type I is characterized by immediate, bilaterally symmetric discharges, generalized over the cortex, lasting longer than type II, and displaying an upward polarity in the spikes.
- Mean Duration of A Single Type II Spike-and-wave Discharge Train [CMO:0002065] — Measurement of the average duration of a single set of type II spike and wave discharges, regular, symmetrical, generalized abnormal electrical discharges in the brain, in a series of episodes separated by normal brain activity, i.e. the average length of time which a type II spike and wave discharge episode lasts. Type II is characterized by local occipital-parietal discharges that are shorter and have less clear waves than spike-wave discharge type I and display an downward polarity in the spikes.
- Mean Length Density of Glomerular Capillaries [CMO:0003708] — This is a calculated value based on the number of capillary profiles counted in microscopic images of glomerular tufts. The total calculated length of capillaries is expressed per glomerulus.
- Mean Platelet Volume [CMO:0001348] — Measurement of the average size of the three dimensional space occupied by a blood platelet, a minute, irregularly shaped, disklike, non-nucleated cytoplasmic body found in blood that functions to promote blood clotting.
- Mean Proximal Tubular Hydraulic Pressure [CMO:0002984] —
- Mean Pulmonary Arterial Blood Pressure [CMO:0000778] — The average blood pressure within the pulmonary artery over a specified period of time, or technically over a complete cycle of one heartbeat.
- Measurement of Minimal Mechanical Stimulus Needed to Elicit Evasive Reaction [CMO:0003567] — A measurement of the pressure of liquid, gas, or solid stimulus which causes the subject to take evasive action to avoid further stimulation. This measurement is often interpreted as the threshold of pain.
- Measurement of Minimal Stimulus Needed to Elicit Evasive Reaction [CMO:0003566] — A measurement of thermal, mechanical, or chemical stimulus which causes the subject to take evasive action to avoid further stimulation.
- Measurement of Minimal Stimulus of Cornea Needed to Elicit Eyelid Blinking [CMO:0003584] — This measurement involves thermal, chemical, or mechanical stimulation of the cornea until the induction of eye blinking.
- Measurement of Prepulse Inhibition of the Acoustic Startle Response [CMO:0002047] — A measurment of the neurological phenomenon in which a weaker prestimulus (prepulse) inhibits the reaction of an organism to a subsequent strong startling stimulus (pulse), that is, a measurement of the reduction in the amplitude of the startle movement caused by an acoustic stimulus/insult following a prepulse.
- Measurement of Stereotypical Movement [CMO:0002142] — Any measurement of abnormal, repetitive, generally non-productive movements which may or may not result in damage to the individual. Such movements are often variations of normal movements or behaviors.
- Measurement of the 50% Threshold of Mechanical Stimulus Needed to Elicit Evasive Reaction [CMO:0003680] — A nociception assay is used to determine the mechanical force required to elicit a paw withdrawal response in 50% of subjects. The calculation is based on the statistical formula used to determine LD50s.
- Measurement of Voluntary Horizontal Locomotion in An Experimental Apparatus [CMO:0001442] — Any measurement of the movement of an organism from one place to another along a plane parallel to the plane of the horizon in a piece of technical equipment or machinery, or in an appliance or device designed for a particular purpose (especially such a movement accomplished by the action of appendages such as flagella, limbs, or wings) originated, undertaken, controlled, or accomplished as a result of free will or choice.
- Measurement of Voluntary Immobility [CMO:0001042] — Any measurement of a movement or quantifiable behavior which does not involve the movement of the organism from one place to another but which originated with or was undertaken, controlled, or accomplished as a result of that organism's free will or choice.
- Measurement of Voluntary Locomotion in An Elevated Plus Maze [CMO:0004021] — Any measurement of the movement of an organism from one place to another in an elevated plus maze apparatus when that movement originated and/or was undertaken, controlled, or accomplished as a result of free will or choice. An elevated plus maze (EPM) is an apparatus with an open center area, two open arms without enclosing walls and two enclosed arms with walls to prevent the experimental subject from escaping or from seeing anything outside the maze. The apparatus is raised a specified distance above the floor and is used to measure movement, behavior, learning, memory, etc., generally in rodents.
- Measurement of Voluntary Locomotion in An Experimental Apparatus [CMO:0000956] — Any measurement of the movement of an organism from one place to another in a piece of technical equipment or machinery, or in an appliance or device designed for a particular purpose (especially such a movement accomplished by the action of appendages such as flagella, limbs, or wings) originated, undertaken, controlled, or accomplished as a result of free will or choice.
- Measurement of Voluntary Locomotion in An Open Field Apparatus [CMO:0004020] — Any measurement of the movement of an organism from one place to another in an open field apparatus when that movement originated and/or was undertaken, controlled, or accomplished as a result of free will or choice. An open field apparatus is an arena, often but not always circular and brightly lit, enclosed in walls of sufficient height to prevent the escape of the experimental subject.
- Measurement of Voluntary Locomotion Into, out of or Within A Discrete Space in An Experimental Apparatus [CMO:0000957] — Any measurement of the movement of an organism from one place to another into, out of or within a distinct and specified area of an experimental apparatus (especially such a movement accomplished by the action of appendages such as flagella, limbs, or wings) originated, undertaken, controlled, or accomplished as a result of free will or choice.
- Meconium Ileus Incidence/prevalence Measurement [CMO:0003880] — Any measurement in which the number of individuals in a study population that display meconium ileuss at a point in time or develop meconium ileus within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Meconium ileus is intestinal obstruction due to inspissated meconium in the distal ileum and cecum, which develops in utero and presents shortly after birth as a failure to pass meconium.
- Medium-sized Liver Metastatic Tumorous Lesion Diameter Measurement [CMO:0003779] — The distance ( 1-3 mm) between two specified opposite points on the periphery of a micrometastatic tumorous lesion found on or in the liver. A micrometastatic tumorous lesion is one that is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cell
- Medulla Oblongata 5-HIAA Level [CMO:0003119] —
- Medulla Oblongata Dopamine Level [CMO:0003121] —
- Medulla Oblongata Catecholamine Level [CMO:0003117] —
- Medulla Oblongata DOPAC Level [CMO:0003120] —
- Medulla Oblongata HVA Level [CMO:0003122] —
- Medulla Oblongata Monoamine Hormone Measurement [CMO:0003116] —
- Medulla Oblongata Norepinephrine Level [CMO:0003123] —
- Medulla Oblongata Ribonucleic Acid Composition Measurement [CMO:0003326] —
- Medulla Oblongata Serotonin Level [CMO:0003118] —
- Mesangial Injury Score [CMO:0002960] — An injury score obtained by multiplying the degree of glomerular damage (0 to 4) with the percentage of the glomeruli with that type of injury (i.e., increase in mesangial matrix material or glomerulosclerosis).
- Mesangium Volume Per Glomerulus [CMO:0003716] — This is a calculated value made by dividing the total mesangial volume measurement by the total number of glomeruli measured, both values having been determined from measurements of microscopic images. Alternately, the fractional mesangial volume (FMV) may be multiplied by the mean glomerular volume (GV) to get the total mesangial volume (TMV).
- Mesangium Volume to Glomerulus Volume Ratio [CMO:0003402] — A calculated value made by dividing the mesangial fraction volume by the total glomerular volume, both values having been calculated from measurements of microscopic images.
- Mesenteric Artery Adventitial Thickness [CMO:0003721] — A measurement of the depth of the tunica adventitia of a mesenteric artery. The tunica adventitia is the outermost layer of the mesenteric arterial wall, composed mainly of fibrous tissue.
- Mesenteric Artery Media Thickness [CMO:0003720] — A measurement of the depth of the tunica media of a mesenteric artery. The tunica media is the middle layer of the mesenteric arterial wall, containing smooth muscle and elastic tissue.
- Mesenteric Artery Molecular Composition Measurement [CMO:0002850] —
- Mesenteric Artery Morphological Measurement [CMO:0002849] —
- Mesenteric Artery Phosphorylated ENOS Level to Total ENOS Level Ratio [CMO:0002852] —
- Mesenteric Artery Wall Thickness [CMO:0003719] — A measurement of the depth of the wall of a mesenteric artery, either of two arteries arising from the aorta and passing between the two layers of the mesentery to the intestine.
- Mesenteric Fat Pad Weight [CMO:0000355] — Weight of the encapsulated adipose tissue attached to the membranous fold or mesentery of the abdomen.
- Mesenteric Fat Pad Weight to Body Weight Ratio [CMO:0000654] — A calculated measurement in which the weight of the mesenteric fat pad, after removal from the body, is measured, divided by the total weight of the body, and presented as a ratio, percentage, fraction or quotient, thus normalizing it to body weight.
- Mesenteric Fat Pad Weight to Tibia Length Ratio [CMO:0003286] —
- Mesenteric Lymph Node Ribonucleic Acid Composition Measurement [CMO:0003379] —
- Metabolic Rate [CMO:0003956] — This is a calculated value which is a measure of the rate of energy expenditure per unit time by endothermic animals at a specific moment or across a specified span of time, under specific conditions.
- Metastatic Intraperitoneal Tumor Weight [CMO:0003554] — The weight of metastatic tumors in the peritoneum. A metastatic tumor in the peritoneum is a secondary, abnormal growth of tissue resulting from the spread of cancer cells to the peritoneum from the place where they first formed.
- Metastatic Liver Tumor Area [CMO:0003651] — A measurement of the average extent of the two-dimensional surface of, or plane through metastatic liver tumors. A metastatic tumor in the liver is a secondary, abnormal growth of tissue resulting from the spread of cancer cells to the liver from the place where they first formed.
- Metastatic Liver Tumor Incidence/prevalence Measurement [CMO:0003870] — Any measurement in which the number of individuals in a study population that display metastatic liver tumors at a point in time or develop metastatic liver tumors within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A metastatic liver tumor is a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive occurring in, but originating distant to the liver.
- Metastatic Liver Tumor Number [CMO:0003610] — A value or quantity determined by count of metastatic tumors in the liver. A metastatic tumor in the liver is a secondary, abnormal growth of tissue resulting from the spread of cancer cells to the liver from the place where they first formed.
- Metastatic Lung Tumor Area Measurement [CMO:0003437] — A measurement of the extent of a two-dimensional surface of or plane through an individual metastatic tumorous lesion in the lung, or a measurement of the average total area occupied by metastatic tumorous lesions in cross-sections of lung per subject.
- Metastatic Lung Tumor Number [CMO:0003434] — A value or quantity determined by count of metastatic tumors in the lung. A metastatic tumor in the lung is a secondary, abnormal growth of tissue resulting from the spread of cancer cells to the lung from the place where they first formed.
- Metastatic Lung Tumor Size Measurement [CMO:0003436] — Any measurement of the size of an individual metastatic tumorous lesion in the lung, or of the amount of the lung occupied by metastatic tumorous lesions. A metastatic tumor in the lung is a secondary abnormal growth of tissue resulting from the spread of cancer cells to the lung from the place where they first formed.
- Metastatic Subcutaneous Tumor Weight [CMO:0003609] — The weight of one or more metastatic tumors measured after growing in the hypodermis, any subcutaneous position in the body. A metastatic subcutaneous tumor is a secondary, abnormal, subcutaneous growth of tissue resulting from the spread of cancer cells from the place where they first formed.
- Metformin Drink Intake Rate [CMO:0002431] — Amount of metformin consumed as or in a drink per unit time. Metformin is an oral antidiabetic drug in the biguanide class which functions to supress the production of glucose by the liver (hepatic gluconeogenesis).
- Methacholine Response/sensitivity Measurement [CMO:0000738] — Measurement of an organism's, organ's, tissue's or cell's capacity to respond, such as by a change in activity, state or condition, to methacholine, a quaternary ammonium ion in which the nitrogen is substituted with three methyl groups and a 2-acetoxypropyl group and which acts as a parasympathomimetic bronchoconstrictor.
- Methylene Blue Metabolism-surface Area Product After Auto-oxidation [CMO:0000710] —
- Methylene Blue Metabolism-surface Area Product Without Auto-oxidation [CMO:0000709] —
- Methylene Blue to FAPGG Metabolism-surface Area Product Ratio [CMO:0000711] — Ratio of the methylene blue metabolism-surface area product without auto-oxidation to the FAPGG metabolism-surface area product.
- MHC Class II RT1A-positive Spinal Cord Ventral Horn Area to Total Spinal Cord Ventral Horn Area Ratio [CMO:0001980] — A calculated measurement in which the value representing the area of the spinal cord vental horn that demonstrates histological staining for the MHC Class II RT1A molecule is divided by value representing the total area of the spinal cord ventral horn, and presented as a ratio, fraction, quotient or percentage. MHC Class II RT1A is a class II major histocompatibility complex protein that is involved in antigen presentation and has been implicated in allograft rejection and autoimmunity.
- Mid-humerus Width [CMO:0001381] — Distance across the humerus, the bone in the upper portion of the forelimb that articulates with the scapula above and the radius and ulna below, measured midway between the two ends of the bone.
- Midbrain Ribonucleic Acid Composition Measurement [CMO:0003929] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) of which the tissue of the midbrain is formed or composed.
- Midbrain/pons 5-HIAA Level [CMO:0003111] —
- Midbrain/pons Catecholamine Level [CMO:0003109] —
- Midbrain/pons DOPAC Level [CMO:0003115] —
- Midbrain/pons Dopamine Level [CMO:0003114] —
- Midbrain/pons HVA Level [CMO:0003113] —
- Midbrain/pons Monoamine Hormone Measurement [CMO:0003108] —
- Midbrain/pons Norepinephrine Level [CMO:0003112] —
- Midbrain/pons Serotonin Level [CMO:0003110] —
- Middle Cerebral Artery Inner Diameter [CMO:0001128] — The length of a line which crosses a transverse view of a middle cerebral artery, passing through its center and ending on either side at the inner surface of the blood vessel wall. The middle cerebral arteries are the largest of the cerebral arteries and supply blood to the lateral cerebral cortex, anterior temporal lobes and insular cortices of the brain.
- Middle Cerebral Artery Outer Diameter [CMO:0003625] — The length of a line which crosses a transverse view of a middle cerebral artery, passing through its center and ending on either side at the outer surface of the blood vessel wall. The middle cerebral arteries are the largest of the cerebral arteries and supply blood to the lateral cerebral cortex, anterior temporal lobes and insular cortices of the brain.
- Middle Ear Measurement [CMO:0002668] — Any measurement of the middle ear, the middle of the three parts of the ear, consisting of an air-filled cavity bound externally by the tympanic membrane and containing three ossicles that vibrate in response to sound waves, passing the amplified sound to the inner ear.
- Middle Ear Morphological Measurement [CMO:0002669] — Any measurement of the physical form or structure of the middle ear, the middle of the three parts of the ear, consisting of an air-filled cavity bound externally by the tympanic membrane and containing three ossicles that vibrate in response to sound waves, passing the amplified sound to the inner ear.
- Middle Frontal Gyrus Ribonucleic Acid Composition Measurement [CMO:0003334] —
- Middle Temporal Gyrus Ribonucleic Acid Composition Measurement [CMO:0003335] —
- Milk Alpha-casein Content [CMO:0000802] — The amount in milk of the alpha fraction of the casein phosphoprotein.
- Milk Alpha-casein Content to Beta-casein Content Ratio [CMO:0002537] — A calculated measurement in which amount of the alpha fraction of the casein phosphoprotein in a specified sample of milk is divided by corresponding amount of the beta fraction of the casein phosphoprotein, and the result presented as a ratio, fraction, quotient or percentage.
- Milk Alpha-casein Percentage [CMO:0000805] — The amount in milk of the alpha fraction of the casein phosphoprotein, expressed as a percentage of total casein content or total milk protein.
- Milk Alpha-lactalbumin Content [CMO:0000809] — The amount in milk of alpha-lactalbumin, an enzyme that catalyzes lactose synthesis in mammary epithelial cells.
- Milk Alpha-lactalbumin Percentage [CMO:0000812] — The amount in milk of alpha-lactalbumin, an enzyme that catalyzes lactose synthesis in mammary epithelial cells, expressed as a percentage of total milk protein.
- Milk Beta Carotene Content [CMO:0000845] — The proportion or amount in milk of a carotenoid that is the most common precursor to vitamin A.
- Milk Beta-casein Content [CMO:0000803] — The amount in milk of the beta fraction of the casein phosphoprotein.
- Milk Beta-casein Percentage [CMO:0000806] — The amount in milk of the beta fraction of the casein phosphoprotein, expressed as a percentage of total casein or total milk protein.
- Milk Beta-lactoglobulin Content [CMO:0000810] — The amount in milk of beta-lactoglobulin, which may bind retinol; this milk constituent is allergenic.
- Milk Beta-lactoglobulin Percentage [CMO:0000813] — The amount in milk of beta-lactoglobulin, which may bind retinol, expressed as a percentage of total whey protein or total protein.
- Milk Casein Content [CMO:0000798] — Measurement of the amount of casein, the predominant phosphoprotein in milk.
- Milk Casein Index [CMO:0000800] — The amount of casein, the predominant phosphoprotein in milk expressed as [(alpha-S1 CN % + alpha-S2 CN % + beta-CN % + kappa-CN %)/(sum of all casein and whey protein %)] x 100.
- Milk Casein Percentage [CMO:0000801] — The amount of casein, the predominant phosphoprotein in milk, expressed as a percentage of total milk protein.
- Milk Conjugated Linoleic Acid Percentage [CMO:0000832] — The amount in milk fat of any/all isomers of linoleic acid in which the double bonds are conjugated, i.e. double bonds alternate with single bonds, expressed as a percentage of total fatty acid amount.
- Milk Fat Content [CMO:0000826] — The amount or concentration of fat in milk.
- Milk Fat Measurement [CMO:0000788] — Measurement of the amount or composition of fat in milk.
- Milk Fat Percentage [CMO:0000816] — The amount of fat in milk, expressed as a percentage of total milk amount.
- Milk Fat Yield [CMO:0000814] — The total amount of milk fat produced over a specific period of time.
- Milk Fat-to-protein Ratio [CMO:0000815] — The ratio of fat yield to protein yield in milk.
- Milk Fatty Acid C10:0 Percentage [CMO:0000834] — The amount in milk fat of a saturated fatty acid with a ten-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C12:0 Percentage [CMO:0000835] — The amount in milk fat of a saturated fatty acid with a twelve-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C12:1(n-3) Percentage [CMO:0000827] — The amount in milk fat of an unsaturated, omega-3 fatty acid with a twelve-carbon backbone and one double bond, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C14:0 Percentage [CMO:0000836] — The amount in milk fat of a saturated fatty acid with a fourteen-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C15:0 Percentage [CMO:0000837] — The amount in milk fat of a saturated fatty acid with a fifteen-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C16:0 Percentage [CMO:0000838] — The amount in milk fat of a saturated fatty acid with a sixteen-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C17:0 Percentage [CMO:0001390] — The amount in milk fat of a saturated fatty acid with a seventeen-carbon backbone, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid C18:0 Percentage [CMO:0000839] — The amount in milk fat of a saturated fatty acid with an eighteen-carbon backbone, expressed as a percentage of total fatty acid content.
- Milk Fatty Acid C18:3 (n-3) Percentage [CMO:0001388] — The amount in milk fat of an unsaturated, omega-3 fatty acid with an eighteen-carbon backbone and three double bonds, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid C20:0 Percentage [CMO:0000840] — The amount in milk fat of a saturated fatty acid with a twenty-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid C24:0 Percentage [CMO:0000841] — The amount in milk fat of a saturated fatty acid with a twenty-four-carbon backbone, expressed as a percentage of total fatty acid content.
- Milk Fatty Acid C4:0 Percentage [CMO:0001391] — The amount in milk fat of a saturated fatty acid with a four-carbon backbone, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid C6:0 Percentage [CMO:0000842] — The amount in milk fat of a saturated fatty acid with a six-carbon backbone, expressed as a percentage of total fatty acid content.
- Milk Fatty Acid C8:0 Percentage [CMO:0000843] — The amount in milk fat of a saturated fatty acid with an eight-carbon backbone, expressed as a percentage of total fatty acid content.
- Milk Fatty Acid Cis-10-C17:1 Percentage [CMO:0001386] — The amount in milk fat of an unsaturated fatty acid with a seventeen-carbon backbone and a cis double bond at C-10, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid Cis-11-C18:1 Percentage [CMO:0001387] — The amount in milk fat of an unsaturated fatty acid with an eighteen-carbon backbone and a cis double bond at C-11, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid Cis-5,8,11,14-C20:4 Percentage [CMO:0001389] — The amount in milk fat of an unsaturated, omega-6 fatty acid with a twenty-carbon backbone and cis double bonds at C-5, C-8, C11, and C-14, expressed as a percentage of the total fatty acid amount.
- Milk Fatty Acid Cis-9,cis-12-C18:2 Percentage [CMO:0000833] — The amount in milk fat of an unsaturated, omega-6 fatty acid with an eighteen-carbon backbone, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid Cis-9-C14:1 Percentage [CMO:0000828] — The amount in milk fat of an unsaturated fatty acid with a fourteen-carbon backbone and a cis double bond at C-9, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid Cis-9-C16:1 Percentage [CMO:0000829] — The amount in milk fat of an unsaturated fatty acid with a sixteen-carbon backbone and a cis double bond at C-9, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid Cis-9-C18:1 Percentage [CMO:0000830] — The amount in milk fat of an unsaturated fatty acid with an eighteen-carbon backbone and a cis double bond at C-9, expressed as a percentage of total fatty acid amount.
- Milk Fatty Acid Measurement [CMO:0000817] — Measurement of the absolute amount or proportion of saturated and/or unsaturated straight chain monocarboxylic (fatty) acids in milk.
- Milk Fatty Acid Trans-11-C18:1 Percentage [CMO:0000831] — The amount in milk fat of an unsaturated fatty acid with an eighteen-carbon backbone and a trans double bond at C-11.
- Milk Kappa-casein Content [CMO:0000804] — The amount in milk of kappa-casein, a casein which plays a crucial role in micellar structure; its concentration determines micellar size.
- Milk Kappa-casein Percentage [CMO:0000807] — The amount in milk of kappa-casein, a casein which plays a crucial role in micellar structure, expressed as a percentage of total milk protein.
- Milk Measurement [CMO:0000787] — Measurement of the constituents or properties of milk, a colloidal emulsion of water, protein, fats and carbohydrates produced by the mammary glands of female mammals.
- Milk Monounsaturated Fatty Acid Measurement [CMO:0000820] — Measurement of the amount of straight chain monocarboxylic acids with only one double or triple carbon-carbon bond found in milk fat.
- Milk Monounsaturated Fatty Acid Percentage [CMO:0001384] — The amount in milk fat of all organic, monobasic acids derived from hydrocarbons in which the carbon chain has only one double or triple carbon-carbon bond, expressed as a percentage of the total fatty acid amount.
- Milk Omega-3 Fatty Acid Measurement [CMO:0000822] — Measurement of the amount of omega-3 fatty acids in milk fat. Omega-3 fatty acids are unsaturated fatty acids in which the first unsaturated bond is in the third (n-3) position from the omega carbon.
- Milk Omega-6 Fatty Acid Measurement [CMO:0000823] — Measurement of the amount of omega-6 fatty acids in milk fat. Omega-6 fatty acids are unsaturated fatty acids in which the first unsaturated bond is in the sixth (n-6) position from the omega carbon.
- Milk Omega-6 to Omega-3 Fatty Acid Ratio [CMO:0001392] — A calculated measurement in which the amount in milk fat of unsaturated, omega-6 fatty acids is divided by the amount of unsaturated, omega-3 fatty acids and expressed as a percentage.
- Milk Palmitoleic to Palmitic Acid Ratio [CMO:0001393] — A calculated measurement in which the amount in milk fat of the 16 carbon monounsaturated fatty acid palmitoleic acid is divided by the amount of the 16 carbon saturated fatty acid palmitic acid and expressed as a percentage.
- Milk Polyunsaturated Fatty Acid Measurement [CMO:0000821] — Measurement of the amount of straight chain monocarboxylic acids with two or more double or triple carbon-carbon bonds found in milk fat.
- Milk Polyunsaturated Fatty Acid Percentage [CMO:0001383] — The amount in milk fat of all organic, monobasic acids derived from hydrocarbons in which the carbon chain has two or more double or triple carbon-carbon bonds, expressed as a percentage of the total fatty acid amount.
- Milk Protein Content [CMO:0000794] — The amount in milk of macromolecules consisting of long sequences of amino acids in peptide linkage.
- Milk Protein Measurement [CMO:0000789] — Measurement of the amount or composition of protein in milk.
- Milk Protein Percentage [CMO:0000795] — The amount in milk of macromolecules consisting of long sequences of amino acids in peptide linkage, expressed as a percentage of total milk amount.
- Milk Protein Yield [CMO:0000796] — The total amount of milk protein produced over a specific period of time.
- Milk Saturated Fatty Acid Measurement [CMO:0000819] — Measurement of the absolute amount or proportion of straight chain monocarboxylic acids without double bonds in their chains found in milk fat.
- Milk Saturated Fatty Acid Percentage [CMO:0001385] — The amount in milk fat of all organic, monobasic acids derived from hydrocarbons in which the carbon chain contains only single carbon-carbon bonds, expressed as a percentage of the total fatty acid amount.
- Milk Solids Content [CMO:0000790] — The amount of fat, protein, lactose, and minerals in milk.
- Milk Somatic Cell Count [CMO:0000792] — The number of somatic cells (leukocytes and epithelial cells) present in milk; a high count is an indicator of mastitis.
- Milk Somatic Cell Measurement [CMO:0000791] — Measurement of the number or composition of somatic cells in milk.
- Milk Somatic Cell Score [CMO:0000793] — Transformation of the number of somatic cells (leukocytes and epithelial cells) present in milk (ln(SCC/100,000)+3).
- Milk Trans Fatty Acid Measurement [CMO:0000824] — Measurement of the amount of unsaturated fatty acids containing at least one double bond in the trans configuration in milk fat.
- Milk Unsaturated Fatty Acid Measurement [CMO:0000818] — Measurement of the absolute amount or proportion of straight chain monocarboxylic acids with one or more double or triple carbon-carbon bonds found in milk fat.
- Milk Urea Nitrogen Content [CMO:0001310] — The amount in milk of the portion of nitrogen that derives from its content of urea.
- Milk Urea Nitrogen Measurement [CMO:0001309] — Any measurement of the urea-associated nitrogen in milk.
- Milk Urea Nitrogen Yield [CMO:0001311] — The total amount of milk urea nitrogen, the portion of nitrogen derived from urea, produced over a specific period of time.
- Milk Vitamin Measurement [CMO:0000844] — Measurement in milk of the amount of an organic substance which occurs in small amounts in food and is necessary in trace amounts for the normal metabolic functioning of the body.
- Milk Whey Protein Content [CMO:0000808] — The combined alpha-lactalbumin and beta-lactoglobulin content in milk.
- Milk Yield [CMO:0001306] — The total amount of milk produced by a lactating mammal over a specific period of time.
- Minimum Rate of Positive Change in Left Ventricular Blood Pressure [CMO:0003288] — A calculated measurement that is used as an index to characterize the contractile ability of the heart.
- Minimum Weekly Bisphenol A in Fructose Drink Intake Rate [CMO:0002175] — The lowest per week intake rate of a fructose solution containing bisphenol A consumed as a drink.
- Minor Salivary Gland Ribonucleic Acid Composition Measurement [CMO:0003314] —
- Minute Ventilation [CMO:0000132] — Total volume of gas inhaled and exhaled from the lungs per one minute.
- Mitogen-stimulated White Blood Cell Radioactive Nucleoside Incorporation [CMO:0002548] — Measurement of the amount of a radioactive nucleoside, such as tritiated (3H-) thymidine, incorporated into white blood cells during a specified period of time following treatment with a substance that induces mitosis resulting in increased cell proliferation. The level of nucleoside incorporation is proportional to the amount of cell proliferation and is used as a measure of the latter.
- Mitral Valve Closure to Opening Time [CMO:0002554] — Measurement of the length of time between the closing of the mitral valve (the dual-flap valve in the heart that controls blood flow between the left atrium and the left ventricle) at the end of ventricular filling (that is, after atrial contraction) and its opening at the beginning of the next round of ventricular filling.
- Mitral Valve Ribonucleic Acid Composition Measurement [CMO:0003301] —
- Mononuclear Cell Count [CMO:0002119] — Determination of the number of mononuclear cells, i.e. leukocytes such as lymphocytes and monocytes with a single round or oval nucleus (including but not limited to such cells found in blood, lymph or spleen) found in a specified sample.
- Mononuclear Cell Interferon Gamma Expression [CMO:0003222] —
- Mononuclear Cell Interferon Gamma Secretion [CMO:0002121] — The amount of interferon gamma (Ifng) secreted (i.e. produced and released) from one or more mononuclear cells. Ifng is a member of the type II interferon family which is a soluble cytokine with antiviral, immunoregulatory and anti-tumor properties and functions as a potent activator of macrophages.
- Mononuclear Cell Measurement [CMO:0002118] — Any measurement of one or more mononuclear cells, i.e. leukocytes such as lymphocytes and monocytes with a single round or oval nucleus (including but not limited to such cells found in blood, lymph or spleen).
- Monophasic Action Potential [CMO:0002860] — Monophasic action potentials (MAPs) are recorded using contact electrode catheters. The recordings provide local information about the actual cellular depolarization and repolarization process of myocardial tissue. They are different from body surface electrocardiographic (ECG) recordings or standard endocardial electrograms, which produce a summative or derivative view of the heart's electrical activity
- Moribundity Measurement [CMO:0001895] — The quantification of any parameter having to do with the state or quality of being on the verge of death or in the process of dying.
- Mortality Measurement [CMO:0001022] — Any quantitative measurement of death, mortality or fatality in an individual or study population. Death is defined as the cessation of all vital functions of the body including the heartbeat, brain activity (including the brain stem), and breathing.
- Mortality/survival Measurement [CMO:0001020] — Any measurement having to do with quantitative measures of mortality, death, fatality or survival of an individual or study population.
- Motile Sperm Count to Total Sperm Count Ratio [CMO:0000638] — Number of sperm which display autokinesia divided by the total number of sperm in a sample, expressed as a percentage.
- Motor Neuron Count [CMO:0001983] — The number of motor neurons (efferent neurons that convey impulses from the central nervous system to muscles, glands, or other effector tissues) in a specified sample.
- Mouth Mucosa Ribonucleic Acid Composition Measurement [CMO:0003338] —
- MRPVAT Ribonucleic Acid Level [CMO:0003972] — This is any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) found in adipose tissue surrounding small mesenteric blood vessels.
- Mucosa Ribonucleic Acid Composition Measurement [CMO:0003355] —
- Multiregional Glomerular Filtration Rate Index [CMO:0003631] — The concentration of a contrast agent in the cortex (predominantly blood signal) from multiple areas of both kidneys is compared to the concentration in multiple areas of the medulla (predominantly urine) of both kidneys to obtain the first order rate constant, k(cl). The clearance of the contrast agent can serve as a marker for the glomerular filtration rate.
- Muscle Fiber Measurement [CMO:0002532] — Any measurement, morphological or physiological of a muscle fiber, any of the cells of skeletal or cardiac muscle tissue. Each cell is one fiber of the muscle.
- Muscle Fiber Morphological Measurement [CMO:0002533] — Any measurement of the physical form or structure of a muscle fiber, any of the cells of skeletal or cardiac muscle tissue. Each cell is one fiber of the muscle.
- Muscle Length [CMO:0002515] — The distance between the two ends, that is, the extent of the longest dimension, of a muscle, an organ which contracts to produce movement.
- Muscle Measurement [CMO:0001158] — Any measurement, morphological or physiological of a muscle or a group of muscles. Muscles are organs or tissues composed of bundles of fibers that have the power to contract and hence to produce movement.
- Muscle Morphological Measurement [CMO:0000127] — Any measurement of the physical form or structure of the skeletal, smooth and/or heart muscles of the body.
- Muscle of Arm Ribonucleic Acid Composition Measurement [CMO:0003292] —
- Muscle of Leg Ribonucleic Acid Composition Measurement [CMO:0003293] —
- Muscle Ribonucleic Acid Composition Measurement [CMO:0002799] — Any measurement of the absolute or relative amount(s) of one or more of the ribonucleic acids (RNAs) of which muscle tissue is formed or composed.
- Muscle Weight [CMO:0000131] — Weight of muscle, an organ which contracts to produce movement.
- Musculature Ribonucleic Acid Composition Measurement [CMO:0003362] —
- Musculoskeletal System Measurement [CMO:0000916] — Measurement of the bodily system that consists of the muscles, bones, joints, and related structures, such as the tendons and connective tissue and which supports and protects the body, functions in the movement of body parts and organs, produces blood cells, and stores minerals.
- Myeloid Leukemia Incidence/prevalence Measurement [CMO:0002275] — Any measurement in which the number of individuals in a study population that display myeloid leukemia, a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid (that is, non-lymphocytic) cells in the bone marrow and the accumulation of these cells in the bone marrow and/or blood, at a point in time or develop myeloid leukemia within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
- Myocardial Clearance Rate [CMO:0001546] — Measurement of the amount of radioactive or other tracer lost from the myocardium, the thick contractile middle layer of uniquely constructed and arranged muscle cells that forms the bulk of the heart wall, per unit time.
- Myocardial Flow Rate [CMO:0001545] — The volume of fluid flowing into, out of or through the blood vessels and microvasculature of the myocardium, the thick contractile middle layer of uniquely constructed and arranged muscle cells that forms the bulk of the heart wall, per unit time.
- Myocardial Performance Index [CMO:0002556] — A calculated measurement comprised of the sum of left ventricular isovolumetric contraction time and isovolumetric relaxation time divided by the left ventricular ejection time.
- Myocardium Measurement [CMO:0001544] — Any measurement of the thick contractile middle layer of uniquely constructed and arranged muscle cells that forms the bulk of the heart wall.
Data returned: 236 terms all with first letter "M".
Data updated: Sep 01, 2024